Conmed (CNMD) Enterprise Value (QoQ) (2010 - 2026)
Conmed (CNMD) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn |
| 10 | Conmed | 1.55 Bn | 1.51 Bn | 197.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.56% |
| Mar 31, 2026 | 14.18% |
| Dec 31, 2025 | -4.85% |
| Sep 30, 2025 | -14.72% |
| Jun 30, 2025 | 4.37% |
| Mar 31, 2025 | -45.08% |
| Dec 31, 2024 | 36.42% |
| Sep 30, 2024 | -33.25% |
| Jun 30, 2024 | 14.73% |
| Mar 31, 2024 | -39.34% |
| Dec 31, 2023 | 20.35% |
| Sep 30, 2023 | -9.53% |
| Jun 30, 2023 | -5.11% |
| Mar 31, 2023 | 8.46% |
| Dec 31, 2022 | 13.23% |
| Sep 30, 2022 | 37.25% |
| Jun 30, 2022 | -113.77% |
| Mar 31, 2022 | -19.27% |
| Dec 31, 2021 | 33.84% |
| Sep 30, 2021 | 32.07% |